JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $33,807 | -80.4% | 18,274 | -88.3% | 0.00% | – |
| Q4 2022 | $172,783 | +23.2% | 155,660 | +159.7% | 0.00% | – |
| Q3 2022 | $140,236 | -11.8% | 59,930 | +14.4% | 0.00% | – |
| Q2 2022 | $159,000 | -26.0% | 52,378 | +65.5% | 0.00% | – |
| Q1 2022 | $215,000 | -19.2% | 31,644 | -0.8% | 0.00% | -100.0% |
| Q4 2021 | $266,000 | +11.8% | 31,895 | -0.3% | 0.00% | – |
| Q3 2021 | $238,000 | +10.2% | 32,000 | +1.0% | 0.00% | – |
| Q2 2021 | $216,000 | +8.0% | 31,693 | +62.3% | 0.00% | – |
| Q1 2021 | $200,000 | – | 19,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |